Meridian Bioscience Inc. (VIVO)
NASDAQ: VIVO
· Real-Time Price · USD
33.97
0.00 (0.00%)
At close: Jan 30, 2023, 10:00 PM
Meridian Bioscience Cash Flow Statement
Financials in USD. Fiscal
year is
October - September.
| Fiscal Year | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 |
Net Income | -2.7M | 42.46M | 43.41M | 62.42M | 59.97M | 71.41M | 71.24M | 87.08M | 70.14M |
Depreciation & Amortization | 16.51M | 16.51M | 16.55M | 16.19M | 15.74M | 13.06M | 13.16M | 12.89M | 12.13M |
Stock-Based Compensation | 6.39M | 6.9M | 5.99M | 5.25M | 4.82M | 4.16M | 4.16M | 4.33M | 4.25M |
Other Working Capital | 27.62M | -988K | -2.67M | 2.23M | -9.44M | -4.04M | -6.47M | -1.65M | 7.03M |
Other Non-Cash Items | 8.4M | 7.75M | 13.7M | -558K | -3.59M | 332K | -2.54M | -3.99M | -2.63M |
Deferred Income Tax | -1.81M | -1.1M | -1.55M | -1.61M | -2.06M | -3.83M | -1.49M | -673K | -511K |
Change in Working Capital | 17.67M | 9.84M | 16.76M | 9.66M | 2.42M | -18.26M | -15.86M | -25.89M | -15.58M |
Operating Cash Flow | 44.46M | 82.36M | 94.85M | 91.35M | 77.3M | 66.86M | 68.68M | 73.75M | 67.81M |
Capital Expenditures | -9.56M | -8.62M | -7.04M | -9.54M | -17.93M | -18.31M | -17.23M | -13.71M | -5.04M |
Cash Acquisitions | -3.75M | -3.75M | -22.34M | -18.59M | -18.59M | -23.59M | -5M | -5M | -5M |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -750K | 1.25M | 1.5M | 1.5M | 1.5M | 1.5M | n/a | -51.3M | -51.3M |
Investing Cash Flow | -14.06M | -11.12M | -27.88M | -26.62M | -35.02M | -40.4M | -22.23M | -70.01M | -61.34M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 8.56M | n/a | -49.02M | -50.57M | -32.16M | -31.07M | -42.33M | 7.59M | -13.56M |
Financial Cash Flow | -25.74M | -34.3M | -49.02M | -50.57M | -32.16M | -31.07M | -42.33M | 7.59M | -13.56M |
Net Cash Flow | 1.37M | 31.68M | 13.47M | 13.11M | 9.54M | -3.74M | 6.57M | 13.82M | -5.36M |
Free Cash Flow | 34.9M | 73.75M | 87.81M | 81.81M | 59.37M | 48.55M | 51.45M | 60.04M | 62.76M |